BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bundle N, Balasegaram S, Parry S, Ullah S, Harris RJ, Ahmad K, Foster GR, Tong CY, Orkin C. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016. Euro Surveill 2019;24. [PMID: 31290390 DOI: 10.2807/1560-7917.ES.2019.24.27.1800377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Maple PAC. Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective. Vaccines (Basel) 2021;9:550. [PMID: 34073985 DOI: 10.3390/vaccines9060550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Anwar WA, El Gaafary M, Girgis SA, Rafik M, Hussein WM, Sos D, Mossad IM, Fontanet A, Temime L. Hepatitis C virus infection and risk factors among patients and health-care workers of Ain Shams University hospitals, Cairo, Egypt. PLoS One 2021;16:e0246836. [PMID: 33556152 DOI: 10.1371/journal.pone.0246836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Martel-Laferriere V, Baril JG, Alarie I, Leblanc J, Côté J, Jourdenais E, Horth D, Lambert G, Tremblay C. Opt-out universal HCV and HIV screening in a Canadian emergency room: a cross-sectional study. BMJ Open 2022;12:e048748. [PMID: 35042704 DOI: 10.1136/bmjopen-2021-048748] [Reference Citation Analysis]